Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Meningococcal Disease
Mass Vaccination Program Dramatically Lowers Transmission In Spain
April 11th, 2001
by N.R. Saltmarsh, staff medical writer - A mass vaccination program to address an upsurge of serogroup C meningococcal disease (SCMD) in Spain led to a decline of SCMD in both the vaccinated and general populations, according to a report in the Journal of Epidemiology and Community Health. L. Salleras and colleagues evaluated a vaccination campaign directed toward the 18-month to 19-year-old age group in the last quarter of 1997. During this campaign, results were tracked via mandatory reporting and a national vaccine register. At two years post-vaccination, the age-adjusted effectiveness of the vaccine was 94%, and only two of the 24...
Source: Vaccine Weekly (2001-04-11)
|
